Susquehanna International Group’s Gain Therapeutics GANX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $143K | Sell |
|
|||||
|
2025
Q1 | $164K | Buy |
|
|||||
|
2024
Q4 | $101K | Buy |
|
|||||
|
2024
Q3 | – | Hold |
|
|||||
|
2024
Q2 | – | Sell |
|
|||||
|
2024
Q1 | $162K | Buy |
|
|||||
|
2023
Q4 | $113K | Sell |
|
|||||
|
2023
Q3 | $211K | Sell |
|
|||||
|
2023
Q2 | $313K | Buy |
|
|||||
|
2023
Q1 | $73.1K | Buy |
|
|||||
|
2022
Q1 | – | Sell |
|
|||||
|
2021
Q4 | $103K | Buy |
|